Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 12, 2022
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
Tue, October 11, 2022
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
Drew Ranieri Maintained (AVNS) at Sell with Decreased Target to $24 on, Oct 11th, 2022
Drew Ranieri of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Decreased Target from $28 to $24 on, Oct 11th, 2022.
Drew has made no other calls on AVNS in the last 4 months.
There are 2 other peers that have a rating on AVNS. Out of the 2 peers that are also analyzing AVNS, 1 agrees with Drew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Rick Wise of "Stifel" Maintained at Hold with Decreased Target to $28 on, Monday, July 18th, 2022
This is the rating of the analyst that currently disagrees with Drew
- Matthew Mishan of "Keybanc" Maintained at Buy with Decreased Target to $38 on, Wednesday, August 10th, 2022
